May 29, 2020 - Page 13 of 17

NASDAQ Companies - May 29, 2020

Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin

MALVERN, Penn., May 29, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]

NASDAQ Companies - May 29, 2020

Regency Centers to Present at Nareit’s REITweek: 2020 Virtual Investor Conference

JACKSONVILLE, Fla., May 29, 2020 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (NASDAQ:REG) today announced that Lisa […]

NASDAQ Companies - May 29, 2020

Pyxis Tankers Announces Date for the Release of the First Quarter 2020 Results and Related Conference Call & Webcast

MAROUSSI, GREECE – May 29, 2020 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), a growth-oriented pure play product tanker […]

NASDAQ Companies - May 29, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant

Elucidation of CD68 as a Downstream Target of Adenosine Refines Adenosine Gene Signature into a Practical Pathology Test Provides Opportunity […]

NASDAQ Companies - May 29, 2020

BeiGene Presents Phase 3 Data on Tislelizumab Combined with Chemotherapy for the Treatment of Patients with Advanced Squamous Non-Small Cell Lung Cancer at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

Phase 3 results comparing tislelizumab plus chemotherapy to chemotherapy alone met its primary endpointCompany to host investor conference call and […]

NASDAQ Companies - May 29, 2020

Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at ASCO20 Virtual Annual Meeting

KEAPSAKE is a planned Phase 2 randomized trial exploring telaglenastat with standard of care in first-line treatment of patients with […]

NASDAQ Companies - May 29, 2020

Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference

CINCINNATI, May 29, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, […]

TSX News - May 29, 2020

Trillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program

Dosing has progressed through first five cohorts up to 4 mg/kg dose levelStrong safety profile, with no dose-limiting toxicities observedMonotherapy […]